JP2013144660A5 - - Google Patents

Download PDF

Info

Publication number
JP2013144660A5
JP2013144660A5 JP2012246031A JP2012246031A JP2013144660A5 JP 2013144660 A5 JP2013144660 A5 JP 2013144660A5 JP 2012246031 A JP2012246031 A JP 2012246031A JP 2012246031 A JP2012246031 A JP 2012246031A JP 2013144660 A5 JP2013144660 A5 JP 2013144660A5
Authority
JP
Japan
Prior art keywords
phosphate
ester
polyoxyethylene
polyethylene glycol
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012246031A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013144660A (ja
JP6018482B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2012246031A priority Critical patent/JP6018482B2/ja
Priority claimed from JP2012246031A external-priority patent/JP6018482B2/ja
Publication of JP2013144660A publication Critical patent/JP2013144660A/ja
Publication of JP2013144660A5 publication Critical patent/JP2013144660A5/ja
Application granted granted Critical
Publication of JP6018482B2 publication Critical patent/JP6018482B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012246031A 2011-12-16 2012-11-08 W/o/w型エマルジョン組成物 Active JP6018482B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2012246031A JP6018482B2 (ja) 2011-12-16 2012-11-08 W/o/w型エマルジョン組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011275424 2011-12-16
JP2011275424 2011-12-16
JP2012246031A JP6018482B2 (ja) 2011-12-16 2012-11-08 W/o/w型エマルジョン組成物

Publications (3)

Publication Number Publication Date
JP2013144660A JP2013144660A (ja) 2013-07-25
JP2013144660A5 true JP2013144660A5 (enExample) 2015-09-24
JP6018482B2 JP6018482B2 (ja) 2016-11-02

Family

ID=49040689

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012246031A Active JP6018482B2 (ja) 2011-12-16 2012-11-08 W/o/w型エマルジョン組成物

Country Status (1)

Country Link
JP (1) JP6018482B2 (enExample)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104084087B (zh) * 2014-06-27 2017-01-25 江南大学 一种含硼、氮的聚乙二醇脂肪酸酯表面活性剂
KR101679334B1 (ko) * 2016-09-02 2016-11-24 이재일 암모니아 처방으로 인한 모발손상과 두피자극 최소화 및 암모니아 냄새 극소화 효과가 있는 염모 조성물 및 그의 제조방법

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57207538A (en) * 1981-06-15 1982-12-20 Kao Corp Emulsifier and emulsified cosmetic material
JPS59161309A (ja) * 1984-02-16 1984-09-12 Kao Corp 乳化化粧料
JPS6186940A (ja) * 1984-10-02 1986-05-02 Kao Corp 水中油型乳化組成物
JPH09263527A (ja) * 1996-03-29 1997-10-07 Shiseido Co Ltd 皮膚外用剤
JP3530079B2 (ja) * 1999-07-15 2004-05-24 三菱化学フーズ株式会社 W/o/w型エマルジョン組成物およびその製造方法
JP2002370925A (ja) * 2001-06-15 2002-12-24 Kose Corp 水中油型乳化化粧料
JP2003275573A (ja) * 2002-03-25 2003-09-30 Sunstar Inc 多相エマルジョン
JP4277135B2 (ja) * 2003-10-31 2009-06-10 サンスター株式会社 W/o/w型エマルション組成物
JP2006281182A (ja) * 2005-03-31 2006-10-19 Sunstar Inc W/o/w型エマルション組成物
JP4659510B2 (ja) * 2005-04-28 2011-03-30 サンスター株式会社 W/o/w型エマルション組成物
JP5220998B2 (ja) * 2006-03-14 2013-06-26 サンスター株式会社 リポソームを含有するw/o/w型皮膚又は頭皮用外用剤
JP2008088104A (ja) * 2006-10-02 2008-04-17 Nikko Chemical Co Ltd W/o/w型乳化物及び外用剤及び化粧料
US20090155194A1 (en) * 2007-12-18 2009-06-18 Schering-Plough Healthcare Products, Inc. Enhanced photostability of avobenzone in the presence of zinc oxide using phosphate-based emulsifiers

Similar Documents

Publication Publication Date Title
EP2909182A4 (en) PREPARATION OF A MEK HEMMER AND FORMULATION WITH A MEK HEMMER
CR20140365A (es) Compuestos de carbamato y preparación y uso de los mismos
EP3630145A4 (en) PHARMACEUTICAL COMPOSITIONS OF CANNABIDIOL AND BETA-CARYOPHYLLENE AND METHOD FOR USING THEM
CL2015001984A1 (es) (divisional de la sol. 1567-2013) combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
MX362702B (es) Compuesto de semifluorocarbono que contiene agente de contraste.
EP3335484A4 (en) PLANNING RADIO AND DIRECT ACCESS RESPONSE (RAR) AND DCI FORMAT
MX2016015636A (es) Formulaciones cannabinoides estables.
CO7111285A2 (es) Composiciones pesticidas y procesos relacionados con ellas
EP2833721A4 (en) NICKEL OXIDE RELEASING PHARMACEUTICAL COMPOSITIONS
EP2783677A3 (de) Formulierung enthaltend Esterquats basierend auf Isopropanolamin
CL2015000295A1 (es) Compuestos derivados de alquilpirimidina; composicion farmaceutica que los comprende; uso para el tratamiento de infecciones víricas y otras enfermedades.
AR094204A1 (es) Composiciones para el cuidado oral que contienen haluros de acido amino
BR112015012547A2 (pt) composições de prostaciclina e métodos de sua utilização
EP2892559A4 (en) ANTIBODY FORMULATIONS AND USES THEREOF
EP2949647A4 (en) DEUTERATED PHENYLAMINOPYRIMIDIN COMPOUND AND PHARMACEUTICAL COMPOSITION THEREWITH
FR3024037B1 (fr) Ingredient actif cosmetique ou dermatologique comprenant un melange d'acides dicarboxyliques gras insatures, compositions le comprenant et utilisations cosmetiques ou dermatologiques
IL257371A (en) Method for the preparation of (4s)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1-6-naphthyridine-3-carboxamide and the purification thereof for use as an active pharmaceutical ingredient
FR3015260B1 (fr) Composition anhydre anti-transpirante sous forme d'aerosol comprenant un actif anti-transpirant et un polymere ethylenique filmogene non hydrosoluble et sequence
DK3710036T3 (da) Stable ascorbic acid compositions and methods of using the same
EP2967053A4 (en) ANTIMICROBIAL COMPOSITIONS AND RELATED METHODS OF USE
JOP20200155B1 (ar) صور متعددة الأشكال
EP2937140A4 (en) RING CATALYST FOR THE PREPARATION OF ACROLEINE AND ACRYLIC ACID AND USE THEREOF
IN2014CN00981A (enExample)
EP3013147A4 (en) COMPOSITIONS WITH PESTICIDE PREPARATIONS AND METHOD OF MANUFACTURE AND USE THEREOF
ES2722926T3 (es) Combinación de levocabastina y furoato de fluticasona para el tratamiento de condiciones inflamatorias y/o alérgicas